Urinary Concentration and Diluting Ability in Patients With Chronic Renal Disease and/ or Hypertension
1 other identifier
observational
50
1 country
1
Brief Summary
The investigators want to test the hypothesis that patients with chronic renal disease have a poorer ability to preserve water after being thirsty and a poorer ability to excrete water after a load of fluid. They presume that these abilities become poorer when renal insufficiency progresses. The investigators further hypothesize that patients with hypertension also have a decreased ability to concentrate and dilute urine.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2004
CompletedFirst Submitted
Initial submission to the registry
April 11, 2006
CompletedFirst Posted
Study publicly available on registry
April 12, 2006
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2008
CompletedAugust 21, 2015
August 1, 2015
3.8 years
April 11, 2006
August 19, 2015
Conditions
Keywords
Study Arms (2)
Dialysis patients
with or wthout glucose added to dialysis fluid
Eligibility Criteria
Healthy participants were recruited by advertisements in public and private institutions Patients with primary hypertension or chronic renal failure were recruited from the Out-patients' Clinic, Department of Medicine, Section of Nephrology, Holstebro Hospital
You may qualify if:
- Patients with chronic renal insufficiency, aged between 18 and 65, both men and women
- Creatinine clearance between 30-59 ml/min
- Patients with hypertension, aged between 18 and 65, both men and women; hypertension is defined as a mean arterial blood pressure in the daytime that is more than 140/90 mm Hg.
- Healthy volunteers, aged between 18 and 65, both men and women
You may not qualify if:
- Clinical signs or history of disease in the heart, lungs, liver, brain, and endocrine organs
- Cancer
- Alcohol abuse
- Medicine abuse
- Pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Medicine, Holstebro Hospital
Holstebro, Ringkjoebing, 7500, Denmark
Related Publications (1)
Pedersen EB, Thomsen IM, Lauridsen TG. Abnormal function of the vasopressin-cyclic-AMP-aquaporin2 axis during urine concentrating and diluting in patients with reduced renal function. A case control study. BMC Nephrol. 2010 Oct 5;11:26. doi: 10.1186/1471-2369-11-26.
PMID: 20923561DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Erling B Pedersen, Professor
Holstebro, Holstebro, Denmark
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- professor, chief physician
Study Record Dates
First Submitted
April 11, 2006
First Posted
April 12, 2006
Study Start
May 1, 2004
Primary Completion
March 1, 2008
Last Updated
August 21, 2015
Record last verified: 2015-08